229 related articles for article (PubMed ID: 30009490)
21. The addition of topical calcipotriol to phototherapy enhance the efficacy of treatment in patients with vitiligo: A systematic review and meta-analysis.
Hu M; Liao K; Lei W; Zhang R; Tu C
Int Immunopharmacol; 2021 Sep; 98():107910. PubMed ID: 34198237
[TBL] [Abstract][Full Text] [Related]
22. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
[TBL] [Abstract][Full Text] [Related]
23. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.
Fenton C; Plosker GL
Am J Clin Dermatol; 2004; 5(6):463-78. PubMed ID: 15663344
[TBL] [Abstract][Full Text] [Related]
24. Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris.
Duweb G; Alhaddar J; Elsherif B; Eljehawi N; Makhlouf H
Drugs Exp Clin Res; 2005; 31(5-6):175-9. PubMed ID: 16425973
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the additional effect of topical 5-fluorouracil to needling in the treatment of localized vitiligo.
Attwa EM; Khashaba SA; Ezzat NA
J Cosmet Dermatol; 2020 Jun; 19(6):1473-1478. PubMed ID: 31524967
[TBL] [Abstract][Full Text] [Related]
26. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo.
Ameen M; Exarchou V; Chu AC
Br J Dermatol; 2001 Sep; 145(3):476-9. PubMed ID: 11531840
[TBL] [Abstract][Full Text] [Related]
27. A statistical analysis plan for the efficiency and safety of Chinese herbal medicine used concurrently with topical therapy for psoriasis vulgaris.
Lu L; Xuan M; Yan Y; Li G; Zhou L; Wen Z; Lu C
Trials; 2016 Oct; 17(1):482. PubMed ID: 27716422
[TBL] [Abstract][Full Text] [Related]
28. Microcirculatory modifications of psoriatic lesions during topical therapy.
Rosina P; Giovannini A; Gisondi P; Girolomoni G
Skin Res Technol; 2009 May; 15(2):135-8. PubMed ID: 19622121
[TBL] [Abstract][Full Text] [Related]
29. A randomized controlled trial to compare calcipotriol with betamethasone valerate for the treatment of cutaneous lichen planus.
Theng CT; Tan SH; Goh CL; Suresh S; Wong HB; Machin D;
J Dermatolog Treat; 2004 Jun; 15(3):141-5. PubMed ID: 15204145
[TBL] [Abstract][Full Text] [Related]
30. A multicentre, randomized, split face and/or neck comparison of 308-nm excimer laser and 0·1% tacrolimus ointment for stable vitiligo plus intramuscular slow-releasing betamethasone for active vitiligo.
Wu Y; Sun Y; Qiu L; Wang H; Zhang Y; Chen K; Li H; Gu H; Zhang J; Gao XH
Br J Dermatol; 2019 Jul; 181(1):210-211. PubMed ID: 30644997
[No Abstract] [Full Text] [Related]
31. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo.
Ada S; Sahin S; Boztepe G; Karaduman A; Kölemen F
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):79-83. PubMed ID: 15752125
[TBL] [Abstract][Full Text] [Related]
32. Treatment of vitiligo by topical calcipotriol.
Chiavérini C; Passeron T; Ortonne JP
J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):137-8. PubMed ID: 12046816
[TBL] [Abstract][Full Text] [Related]
33. Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study.
Li L; Wu Y; Li L; Sun Y; Qiu L; Gao XH; Chen HD
Dermatol Ther; 2015; 28(3):131-4. PubMed ID: 25753514
[TBL] [Abstract][Full Text] [Related]
34. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
[TBL] [Abstract][Full Text] [Related]
35. A comparative study on the use of fractional CO
Bakr RM; Abdel-Gaber RM; Tawfik YM
Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
[TBL] [Abstract][Full Text] [Related]
36. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of topical therapy combined with 308-nm excimer laser on vitiligo compared to excimer laser monotherapy in pediatric patients.
Li L; Liang Y; Hong J; Lan L; Xiao H; Xie Z
Pediatr Dermatol; 2019 Jan; 36(1):e53-e55. PubMed ID: 30520111
[TBL] [Abstract][Full Text] [Related]
38. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol/betamethasone in combination with NBUVB in treatment of vitiligo.
Alshiyab D; Al-Qarqaz F; Ba-Shammakh S; Al-Fakih A; Altawalbeh A; Alsheyab S; Sarakbi D; Muhaidat J
J Dermatolog Treat; 2023 Dec; 34(1):2252119. PubMed ID: 37644869
[No Abstract] [Full Text] [Related]
40. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
